[ET Net News Agency, 1 August 2025] AKESO (09926) rose 3.6% to HK$160.1.
It hits an intra-day high of HK$160.5, hitting a historical high, and an intra-day low of HK$153.6. The total shares traded was 1.34 million, with a value of HK$210.54m. The active buy/sell ratio is 76:24, with net buying turnover of HK$100.74m. DBS VICKERS (HK) accounts for greatest net responsive buying turnover of HK$7.64m, with volume weighted average price of HK$158.952. CHINA INNOVATION MARKET SER accounts for greatest net responsive selling turnover of HK$25.84m, with volume weighted average price of HK$158.197. The stock has risen a combined 4.8% over the past 2 consecutive trading days.
Basic Information| Nominal | 160.100 | % Chg | +3.56% |
| High | 160.500 | Low | 153.600 |
| Shares Tr | 1.34m | Turnover | 210.54m |
| 10-D SMA | 150.770 | %H.V | 61.632 |
| 20-D SMA | 135.345 | VWAP | 157.573 |
| 50-D SMA | 108.716 | RSI14 | 77.406 |
Status: Hitting a historical high, active buy/sell ratio is 76:24, with net buying turnover of HK$100.74m, rising a combined 4.8% over the past 2 consecutive trading days
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| AKESO (09926) | 160.10 | +3.56 |
| SINO BIOPHARM (01177) | 7.58 | +0.80 |
| 3SBIO (01530) | 32.15 | +0.16 |
| EVEREST MED (01952) | 63.75 | -0.23 |
| KEYMED BIO-B (02162) | 62.50 | +1.79 |
| WUXI XDC (02268) | 58.80 | +1.91 |
| ASCENTAGE-B (06855) | 73.80 | +2.50 |
| SKB BIO-B (06990) | 417.20 | +0.29 |
| ZAI LAB (09688) | 29.90 | +1.87 |
| REMEGEN (09995) | 60.95 | +1.08 |
(ed)
